What's in I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio's pipeline?

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio has 6 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/i-r-c-c-s-ospedale-galeazzi-sant-ambrogio.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio pipeline: 3 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Didrogyl	Didrogyl	marketed			Other
prasugrel/bivalirudin	prasugrel/bivalirudin	marketed	Antiplatelet agent + Direct thrombin inhibitor combination	P2Y12 receptor (prasugrel); Thrombin (bivalirudin)	Cardiovascular
clopidogrel/abciximab	clopidogrel/abciximab	marketed	Dual antiplatelet agent (P2Y12 inhibitor + glycoprotein IIb/IIIa inhibitor)	P2Y12 receptor (clopidogrel); glycoprotein IIb/IIIa integrin (abciximab)	Cardiovascular

Therapeutic area mix

Cardiovascular · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio:

Cite this brief

Drug Landscape (2026). I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/i-r-c-c-s-ospedale-galeazzi-sant-ambrogio. Accessed 2026-05-17.